GFM Network News


Elanco Animal Health wins U.S. approval to buy Bayer unit

Elanco to shed cattle pour-on brand, others for approval

Washington | Reuters — Elanco Animal Health has won U.S. antitrust approval to buy Bayer’s animal health business on condition that it sell assets to treat three ailments, two in dogs and one in cattle, the Federal Trade Commission said on Wednesday. The deal was valued at $7.6 billion when it was announced in August […] Read more

Elanco forgoes Canadian poultry insecticide rights for Bayer deal

Reuters — Elanco Animal Health has decided against acquiring Bayer’s Canadian distribution rights to several poultry insecticides, Canada’s Competition Bureau said on Tuesday, as it looks to complete a $7.6-billion deal. The U.S.-based company will also divest its canine ear infection treatment product Osurnia and Bayer’s feline dewormer Profender to address competition concerns about its […] Read more


Elanco gets EU’s conditional antitrust OK for Bayer deal

Approval calls for sale of Vecoxan brand, among others

Reuters/Staff — Elanco Animal Health secured antitrust clearance on Monday from the European Union to buy Bayer’s veterinary drugs unit, after pledging to sell some products to address competition concerns about the US$7.6 billion deal. The European Commission said the companies will sell either Elanco or Bayer’s products or those in the pipeline, including licenses, […] Read more




Elanco buys swine PWD vaccine maker

Veterinary drugmaker Elanco Animal Health is expanding its space in the swine sector with a deal to buy the Quebec startup behind Coliprotec vaccines. Indianapolis-based Elanco announced Thursday it has paid $78.5 million to buy Prevtec Microbia, which is headquartered in Montreal with facilities in St-Hyacinthe. The Coliprotec line is meant to help protect pigs […] Read more